Non-Hodgkin's Lymphoma Incidence

In epidemiology, "incidence rate" is a measure of how many people within a given population will develop a disease or other condition during a specified period of time. It is, essentially, a measurement of risk.

The National Cancer Institute estimates that 65,980 new cases of Non-Hodgkin's Lymphoma will be diagnosed in 2009. This represents 89% of all lymphomas, and 4% of all cancers diagnosed. It is the seventh most common cancer in the United States.

According to the Leukemia and Lymphoma Society:

  • The chance of developing Non-Hodgkin's Lymphoma during your lifetime is 1 in 50, or 2%. However, this percentage increases if you have one or more risk factors for the disease.
  • NHL is more prevalent in males than females–55% of lymphoma diagnoses are for male patients
  • Of those diagnosed with the disease, 95% are adults and 5% are children
  • It is more prevalent in patients over the age of 60
  • The average age at diagnosis is 65
  • Due to aging of the "baby boom" population, the incidence of NHL is expected to rise in the coming years

Lymphoma is a well-researched subject and many statistics are published annually. For the most up-to-date and complete statistical information on lymphoma, please see the resources listed at the bottom of the page.

Lymphoma statistics resources

Related Articles

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...